<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35426522</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0460</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Dysphagia</Title><ISOAbbreviation>Dysphagia</ISOAbbreviation></Journal><ArticleTitle>Impact of Limb Phenotype on Tongue Denervation Atrophy, Dysphagia Penetrance, and Survival Time in a Mouse Model of ALS.</ArticleTitle><Pagination><StartPage>1777</StartPage><EndPage>1795</EndPage><MedlinePgn>1777-1795</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00455-022-10442-4</ELocationID><Abstract><AbstractText>Current treatments for dysphagia in ALS do not target the underlying tongue weakness and denervation atrophy that is prevalent in spinal and bulbar ALS cases. To address this clinical gap, we studied the low copy number SOD1-G93A (LCN-SOD1) mouse model of ALS to quantify the impact of limb phenotype on tongue denervation atrophy, dysphagia penetrance, and survival time in preparation for future treatment-based studies. Two male LCN-SOD1 breeders and 125 offspring were followed for limb phenotype inheritance, of which 52 (30 LCN-SOD1 and 22 wild-type/WT, both sexes) underwent characterization of dysphagia penetrance (via videofluoroscopic swallow study; VFSS) and survival time at disease end-stage (15-20% body weight loss). From these, 16 mice (8/genotype) underwent postmortem histological analysis of the genioglossus for evidence of denervation atrophy. Results revealed that both breeders displayed a mixed (hindlimb and forelimb) ALS phenotype and sired equal proportions of hindlimb vs. mixed phenotype offspring. Dysphagia penetrance was complete for mixed (100%) versus incomplete for hindlimb (64%) phenotype mice; yet survival times were similar. Regardless of limb phenotype, LCN-SOD1 mice had significantly smaller genioglossus myofibers and more centralized myonuclei compared to WT mice (p&#x2009;&lt;&#x2009;0.05). These biomarkers of denervation atrophy were significantly correlated with VFSS metrics (lick and swallow rates, p&#x2009;&lt;&#x2009;0.05) but not survival time. In conclusion, both LCN-SOD1 phenotypes had significant tongue denervation atrophy, even hindlimb phenotype mice without dysphagia. This finding recapitulates human ALS, providing robust rationale for using this preclinical model to explore targeted treatments for tongue denervation atrophy and ensuing dysphagia.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mueller</LastName><ForeName>Marissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Thompson</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>Kate L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Missouri School of Medicine, One Hospital Dr. MA314, Columbia, MO, 65212, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andel</LastName><ForeName>Ellyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeJonge</LastName><ForeName>Chandler A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kington</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephenson</LastName><ForeName>Zola</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamad</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Missouri Students, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunyak</LastName><ForeName>Filiz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Electrical Engineering and Computer Science, University of Missouri College of Engineering, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Missouri College of Veterinary Medicine, Columbia, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lever</LastName><ForeName>Teresa E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0002-5587-3816</Identifier><AffiliationInfo><Affiliation>Department of Otolaryngology - Head and Neck Surgery, University of Missouri School of Medicine, One Hospital Dr. MA314, Columbia, MO, 65212, USA. levert@health.missouri.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Missouri College of Veterinary Medicine, Columbia, MO, USA. levert@health.missouri.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL153612</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 DC016071</GrantID><Acronym>DC</Acronym><Agency>NIDCD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dysphagia</MedlineTA><NlmUniqueID>8610856</NlmUniqueID><ISSNLinking>0179-051X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003680" MajorTopicYN="Y">Deglutition Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019683" MajorTopicYN="N">Penetrance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014059" MajorTopicYN="N">Tongue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003714" MajorTopicYN="N">Denervation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Denervation atrophy</Keyword><Keyword MajorTopicYN="N">Dysphagia</Keyword><Keyword MajorTopicYN="N">Genioglossus</Keyword><Keyword MajorTopicYN="N">Mouse model</Keyword><Keyword MajorTopicYN="N">Phenotype</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>12</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35426522</ArticleId><ArticleId IdType="mid">NIHMS1808125</ArticleId><ArticleId IdType="pmc">PMC9568622</ArticleId><ArticleId IdType="doi">10.1007/s00455-022-10442-4</ArticleId><ArticleId IdType="pii">10.1007/s00455-022-10442-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruijn LI, Miller TM, Cleveland DW: Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723&#x2013;749, 2004.</Citation><ArticleIdList><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, Loeffler JP, Dupuis L: Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem 101: 1153&#x2013;1160, 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17250677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Appel S, Baloh RH, Barohn R, Brooks BR, Elman L, Floeter MK, Henderson C, Lomen-Hoerth C, Macklis JD, McCluskey L, Mitsumoto H, Przedborski S, Rothstein J, Trojanowski JQ, van den Berg LH, Ringel S: Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener 14 Suppl 1: 5&#x2013;18, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3779649</ArticleId><ArticleId IdType="pubmed">23678876</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC: Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12: 310&#x2013;322, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, Diseases WFoNRGoMN: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293&#x2013;299, 2000.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JD, Borasio GD: Amyotrophic lateral sclerosis. . Lancet 369: 2031&#x2013;2041, 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>Weikamp JG, Schelhaas HJ, Hendriks JC, de Swart BJ, Geurts AC: Prognostic value of decreased tongue strength on survival time in patients with amyotrophic lateral sclerosis. J Neurol 259: 2360&#x2013;2365, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484270</ArticleId><ArticleId IdType="pubmed">22527240</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemoto G, Furuya H, Tsuboi Y, Fujioka S, Arahata H, Sugahara M, Sakai M: Characteristics of tongue and pharyngeal pressure in patients with neuromuscular diseases. Degener Neurol Neuromuscul Dis 7: 71&#x2013;78, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053096</ArticleId><ArticleId IdType="pubmed">30050379</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor L, Gaziano J, Watts S, Robison R, Plowman EK: Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis. Dysphagia 31: 376&#x2013;382, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871719</ArticleId><ArticleId IdType="pubmed">26837611</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P: Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53: 1059&#x2013;1063, 1999.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Dworkin JP: Tongue strength measurement in patients with amyotrophic lateral sclerosis: qualitative vs quantitative procedures. Arch Phys Med Rehabil 61: 422&#x2013;424, 1980.</Citation><ArticleIdList><ArticleId IdType="pubmed">7416933</ArticleId></ArticleIdList></Reference><Reference><Citation>DePaul R, Abbs JH, Caligiuri M, Gracco VL, Brooks BR: Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38: 281&#x2013;283, 1988.</Citation><ArticleIdList><ArticleId IdType="pubmed">3340294</ArticleId></ArticleIdList></Reference><Reference><Citation>DePaul R, Brooks BR: Multiple orofacial indices in amyotrophic lateral sclerosis. J Speech Hear Res 36: 1158&#x2013;1167, 1993.</Citation><ArticleIdList><ArticleId IdType="pubmed">8114482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Jesse S: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials. Ther Adv Neurol Disord 2: 319&#x2013;326, 2009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3002601</ArticleId><ArticleId IdType="pubmed">21180622</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O: ALS Clinical Trials Review: 20 Years of Failure Are We Any Closer to Registering a New Treatment?. Front Aging Neurosci 9: 68, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360725</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal MK: Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med Res Rev 39: 733&#x2013;748, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30101496</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman KL, Kohlberg S, Mok A, Brooks R, Lind LA, McCormack K, Ferreira A, Kadosh M, Fagan MK, Bearce E, Nichols NL, Coates JR, Lever TE: Optimizing the Translational Value of Mouse Models of ALS for Dysphagia Therapeutic Discovery. Dysphagia 35: 343&#x2013;359, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6954990</ArticleId><ArticleId IdType="pubmed">31300881</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto N, Yamashita T, Sato K, Kurata T, Ikeda Y, Kusuhara T, Murata N, Abe K: Assessment of swallowing in motor neuron disease and Asidan/SCA36 patients with new methods. J Neurol Sci 324: 149&#x2013;155, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">23146615</ArticleId></ArticleIdList></Reference><Reference><Citation>Epps D, Kwan JY, Russell JW, Thomas T, Diaz-Abad M: Evaluation and Management of Dysphagia in Amyotrophic Lateral Sclerosis: A Survey of Speech-Language Pathologists' Clinical Practice. J Clin Neuromuscul Dis 21: 135&#x2013;143, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034365</ArticleId><ArticleId IdType="pubmed">32073459</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders I, Mu L: A three-dimensional atlas of human tongue muscles. Anat Rec (Hoboken) 296: 1102&#x2013;1114, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3687025</ArticleId><ArticleId IdType="pubmed">23650264</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey EF: Activities of human genioglossus motor units. Respiratory physiology &amp; neurobiology 179: 14&#x2013;22, 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3175270</ArticleId><ArticleId IdType="pubmed">21558022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S, Della Gatta PA, Russell AP: Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS. Front Physiol 7: 403, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5020084</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur K, Nagy JA, Taylor RS, Sanchez B, Rutkove SB: Estimating Myofiber Size With Electrical Impedance Myography: a Study In Amyotrophic Lateral Sclerosis MICE. Muscle Nerve 58: 713&#x2013;717, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6246784</ArticleId><ArticleId IdType="pubmed">30175407</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy JA, DiDonato CJ, Rutkove SB, Sanchez B: Permittivity of ex vivo healthy and diseased murine skeletal muscle from 10 kHz to 1 MHz. Sci Data 6: 37, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6472406</ArticleId><ArticleId IdType="pubmed">31000708</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen L, Jorgensen LH, Bech RD, Frandsen U, Schroder HD: Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. Biomed Res Int 2016: 5930621, 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4852332</ArticleId><ArticleId IdType="pubmed">27195289</ArticleId></ArticleIdList></Reference><Reference><Citation>Folker ES, Baylies MK: Nuclear positioning in muscle development and disease. Front Physiol 4: 363, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3859928</ArticleId><ArticleId IdType="pubmed">24376424</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk A: Denervation: ALS. NEUROMUSCULAR DISEASE CENTER Washington University, St. Louis, MO USA</Citation></Reference><Reference><Citation>Al-Sarraj S, King A, Cleveland M, Pradat PF, Corse A, Rothstein JD, Leigh PN, Abila B, Bates S, Wurthner J, Meininger V: Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathol Commun 2: 165, 2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4297389</ArticleId><ArticleId IdType="pubmed">25510661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Pioro EP: Familial ALS with SOD1 mutation misdiagnosed with polyradiculopathy and myopathy. Amyotroph Lateral Scler 10: 476&#x2013;478, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19922143</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A: Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis. Neurol India 61: 107&#x2013;110, 2013.</Citation><ArticleIdList><ArticleId IdType="pubmed">23644307</ArticleId></ArticleIdList></Reference><Reference><Citation>Manera U, Calvo A, Daviddi M, Canosa A, Vasta R, Torrieri MC, Grassano M, Brunetti M, D'Alfonso S, Corrado L, De Marchi F, Moglia C, D'Ovidio F, Mora G, Mazzini L, Chio A: Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 91: 291&#x2013;297, 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">31871138</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M, Figueiral M, Uysal H, Grosskreutz J, Kuzma-Kozakiewicz M, Pinto S, Petri S, Madeira S, Swash M, de Carvalho M: Spreading in ALS: The relative impact of upper and lower motor neuron involvement. Ann Clin Transl Neurol 7: 1181&#x2013;1192, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359118</ArticleId><ArticleId IdType="pubmed">32558369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al.: Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772&#x2013;1775, 1994.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME: The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci 152 Suppl 1: S67&#x2013;73, 1997.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever TE, Gorsek A, Cox KT, O'Brien KF, Capra NF, Hough MS, Murashov AK: An animal model of oral dysphagia in amyotrophic lateral sclerosis. Dysphagia 24: 180&#x2013;195, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19107538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever TE, Simon E, Cox KT, Capra NF, O'Brien KF, Hough MS, Murashov AK: A mouse model of pharyngeal dysphagia in amyotrophic lateral sclerosis. Dysphagia 25: 112&#x2013;126, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">19495873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever TE, Braun SM, Brooks RT, Harris RA, Littrell LL, Neff RM, Hinkel CJ, Allen MJ, Ulsas MA: Adapting human videofluoroscopic swallow study methods to detect and characterize dysphagia in murine disease models. J Vis Exp, 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4401177</ArticleId><ArticleId IdType="pubmed">25866882</ArticleId></ArticleIdList></Reference><Reference><Citation>Lever TE, Brooks RT, Thombs LA, Littrell LL, Harris RA, Allen MJ, Kadosh MD, Robbins KL: Videofluoroscopic Validation of a Translational Murine Model of Presbyphagia. Dysphagia 30: 328&#x2013;342, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25783697</ArticleId></ArticleIdList></Reference><Reference><Citation>Welby L, Caudill H, Yitsege G, Hamad A, Bunyak F, Zohn IE, Maynard T, LaMantia AS, Mendelowitz D, Lever TE: Persistent Feeding and Swallowing Deficits in a Mouse Model of 22q11.2 Deletion Syndrome. Front Neurol 11: 4, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7006055</ArticleId><ArticleId IdType="pubmed">32082240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind LA, Lever TE, Nichols NL: Tongue and hypoglossal morphology after intralingual CTB-saporin injection. Muscle Nerve, 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117177</ArticleId><ArticleId IdType="pubmed">33269488</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeuf-Louchart A, Hardy D, Thorel Q, Roux P, Gueniot L, Briand D, Mazeraud A, Bougle A, Shorte SL, Staels B, Chretien F, Duez H, Danckaert A: MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool. Skelet Muscle 8: 25, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091189</ArticleId><ArticleId IdType="pubmed">30081940</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A: Fiji: an open-source platform for biological-image analysis. Nat Methods 9: 676&#x2013;682, 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kletzien H, Hare AJ, Leverson G, Connor NP: Age-related effect of cell death on fiber morphology and number in tongue muscle. Muscle Nerve 57: E29&#x2013;E37, 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5656552</ArticleId><ArticleId IdType="pubmed">28440544</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D, Teuling E, Haasdijk ED, De Zeeuw CI, Hoogenraad CC: Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J Neurosci 28: 2075&#x2013;2088, 2008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671838</ArticleId><ArticleId IdType="pubmed">18305242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceglia L, Niramitmahapanya S, Price LL, Harris SS, Fielding RA, Dawson-Hughes B: An evaluation of the reliability of muscle fiber cross-sectional area and fiber number measurements in rat skeletal muscle. Biol Proced Online 15: 6, 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599694</ArticleId><ArticleId IdType="pubmed">23497012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Cutting FB, Zhai P, Andrus PK, Hall ED: Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase. Pathol Biol (Paris) 44: 51&#x2013;56, 1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">8734301</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N: Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 21: 82&#x2013;92, 2001.</Citation><ArticleIdList><ArticleId IdType="pubmed">11304046</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamolhoda M, Ayatollahi SMT, Bagheri Z: A comparative study of the impacts of unbalanced sample sizes on the four synthesized methods of meta-analytic structural equation modeling. BMC Res Notes 10: 446, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585956</ArticleId><ArticleId IdType="pubmed">28877742</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ: Use of proper statistical techniques for research studies with small samples. Am J Physiol Lung Cell Mol Physiol 313: L873&#x2013;L877, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28982734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdowsian HR, Beck N: Ethical and scientific considerations regarding animal testing and research. PLoS One 6: e24059, 2011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168484</ArticleId><ArticleId IdType="pubmed">21915280</ArticleId></ArticleIdList></Reference><Reference><Citation>Peggion C, Massimino ML, Biancotto G, Angeletti R, Reggiani C, Sorgato MC, Bertoli A, Stella R: Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis. Anal Bioanal Chem 409: 2143&#x2013;2153, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28078418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T: Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28: 154&#x2013;164, 2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciote JJ, Horton MJ, Rowlerson AM, Link J: Specialized cranial muscles: how different are they from limb and abdominal muscles? Cells Tissues Organs 174: 73&#x2013;86, 2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848039</ArticleId><ArticleId IdType="pubmed">12784043</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlath GK, Thaloor D, Rando TA, Cheong M, English AW, Zheng B: Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev Dyn 212: 495&#x2013;508, 1998.</Citation><ArticleIdList><ArticleId IdType="pubmed">9707323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalrymple KR, Prigozy TI, Mayo M, Kedes L, Shuler CF: Murine tongue muscle displays a distinct developmental profile of MRF and contractile gene expression. Int J Dev Biol 43: 27&#x2013;37, 1999.</Citation><ArticleIdList><ArticleId IdType="pubmed">10213080</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J, Cashman NR: Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb Perspect Med 7, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538408</ArticleId><ArticleId IdType="pubmed">28003278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhenfei L, Shiru D, Xiaomeng Z, Cuifang C, Yaling L: Discontiguous or Contiguous Spread Patterns Affect the Functional Staging in Patients With Sporadic Amyotrophic Lateral Sclerosis. Front Neurol 10: 523, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6540586</ArticleId><ArticleId IdType="pubmed">31191429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>